US Patent 7935343 Human antibody molecules for IL-13

Patent 7935343 was granted and assigned to Medimmune Limited on May, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

79353430

Patent Inventor Names

Celia Patricia Shorrock0

Ralph Raymond Minter0

Phillip David Monk0

Lutz Ulrich Jochen Jermutus0

Date of Patent

May 3, 2011

Patent Application Number

108919720

Date Filed

July 15, 2004

Patent Primary Examiner

‌

Zachary Skelding

Patent abstract

Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.